ARCHIVES

NCI “Leadership Vacuum” Deepened?

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012